Didier Buffet

Passionate about health and ethics issues, I had the chance with Pharmion and then Celgene to participate in the advent of immunotherapy by participating in the marketing in France of Imids from the beginning of the 2000s.

I wish to see the cure of an increasing number of cancers and I do this by promoting the Good Use of drugs with as much scientific rationale as possible, thus guaranteeing the best benefit/risk ratio for patients.